Activity

Charles & Colvard (CTHR) was delisted from the Nasdaq Stock Market due to non-compliance with Nasdaq listing rules. Specifically, the company failed to file its required periodic financial reports in a timely manner.
Here’s a breakdown of the situation:
* Failure to File Timely Reports: Charles & Colvard did not file its Form 10-Q for the quarters ending September 30, 2024, and December 31, 2024, on time.
* Nasdaq Notification: In October 2024, Nasdaq notified the company that it was not in compliance with the listing rule requiring the timely filing of all necessary periodic reports.
* Confidential Arbitration: The company had stated that the delay in filing was partly due to the “pending outcome of confidential arbitration against the company” with Wolfspeed.
* No Intention to Appeal: Charles & Colvard announced that it would not request a hearing to appeal Nasdaq’s delisting determination.
* Cost Considerations: The company stated that the decision to not appeal was based on a careful review of several factors, including the potential for limiting the significant costs associated with remaining listed on Nasdaq and complying with its listing standards.
* Trading Suspension: Trading of Charles & Colvard’s common stock on Nasdaq was suspended at the opening of business on April 25, 2025.
* OTC Experts Market: Following the delisting, the company expects its common stock to be quoted on the OTC Experts Market. However, there is no guarantee that a trading market in the stock will be maintained on any over-the-counter market.
In summary, Charles & Colvard was delisted from Nasdaq because it failed to meet the exchange’s requirements for timely financial reporting, and the company chose not to appeal this decision, citing cost-saving reasons.

Video courtesy of ABN-AMRO

Video courtesy of ABN-AMRO